bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
All Web sites
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2013: M A M F J
2012: D N O S A J J M

 
  Other news for:
Heartburn
Omeprazole
 Resources from HONselect
Heartburn Meds May Often Be Taken for Too Long, at Too-High Doses
Study of U.S. veterans found many stay on drugs such as Prilosec for months, years without reevaluation

By Robert Preidt

FRIDAY, Feb. 22 (HealthDay News) -- U.S. veterans with chronic heartburn are often prescribed higher-than-recommended doses of medicines to control the condition and many are kept on the drugs far too long, according to a new study.

Researchers looked at 1,600 veterans who were diagnosed with chronic heartburn -- also known as gastroesophageal reflux disease (GERD) -- and prescribed a type of drug called a "proton pump inhibitor," such as Prilosec (omeprazole).

GERD arises when the ring of muscle between the esophagus and stomach fails to close properly, allowing stomach acids to splash up into the esophagus. The main symptom is chronic heartburn.

These drugs -- which also include Prevacid (lansoprazole) and Nexium (esomeprazole) -- are among the most widely used drugs in the United States and provide relief for many patients with chronic heartburn. However, proper prescribing is required to avoid prolonged and unnecessary use, according to study first author Dr. Andrew Gawron, a fellow in the gastroenterology division and the Center for Healthcare Studies at Northwestern University Feinberg School of Medicine, in Chicago.

He and his colleagues found that most of the veterans in the study received more than a three-month initial supply of proton pump inhibitor medication and that nearly one-quarter of them were given high doses.

Only a few of the patients who were started on a high dose of this kind of medication had reductions in dosing more than two years after their initial prescription, according to the study published Feb. 16 in the Journal of General Internal Medicine.

The researchers noted that it is recommended that proton pump inhibitors be prescribed at the lowest effective dose for the first four to eight weeks. If symptoms persist after eight weeks, doctors should try to find other potential causes of symptoms and different types of treatment.

"We should always have a reevaluation after an initial prescription and ask, 'Does this patient need to be on this medication?'" Gawron said in a university news release.

However, he said this study shows that "once these veterans are prescribed a [proton pump inhibitor], they are rarely taken off of it. Two years after their initial prescription, most are still on the drug."

More information

The U.S. National Institute of Diabetes and Digestive and Kidney Diseases has more about GERD.

SOURCE: Northwestern University, news release, Feb. 20, 2013

Health News Copyright © 2013 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=673713

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Heartburn
Veterans
Specialty Chemicals and Products
Protons
Research Personnel
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact